Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 11, 2023, titled "Zydus andDaewoong Pharmaceutical announce exclusive licensing agreement for development andcommercialization of Leuprolide Long-Acting Injectable in the U.S.".
Zydus Lifesciences Limited Press Release Dec 11 2023
Filed with NSE · · 3 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Dec 06 2023
- Press Release Dec 01 2023
- Press Release Nov 10 2023
- Press Release Nov 07 2023
- Press Release Nov 06 2023
Later from Zydus Lifesciences
- Press Release Dec 14 2023
- Press Release Dec 15 2023
- Press Release Dec 16 2023
- Press Release Dec 22 2023
- Press Release Jan 17 2024
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences